Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Potentiating the Antitumor Activity of Cytotoxic T Cells the Transmembrane Domain of IGSF4 That Increases TCR Avidity

Front Immunol. 2021-02; 
Hye-Ran Kim, Jeong-Su Park, Yasmin Fatima, Maiza Kausar, Jin-Hwa Park, Chang-Duk Jun
Products/Services Used Details Operation
Peptide Synthesis … OVA peptide fragments (323–339 and 257–264) were purchased from GenScript (San Diego, CA, USA). APC-CD69 (12-0691-82), APC-anti-CD62L, and Percp-Cy5.5-CD44 were purchased from eBioscience (San Diego, CA, USA) … Get A Quote

摘要

A robust T-cell response is an important component of sustained antitumor immunity. In this respect, the avidity of TCR in the antigen-targeting of tumors is crucial for the quality of the T-cell response. This study reports that the transmembrane (TM) domain of immunoglobulin superfamily member 4 (IGSF4) binds to the TM of the CD3 ζ-chain through an interaction between His177 and Asp36, which results in IGSF4-CD3 ζ dimers. IGSF4 also forms homo-dimers through the GxxVA motif in the TM domain, thereby constituting large TCR clusters. Overexpression of IGSF4 lacking the extracellular (IG4ΔEXT) domain potentiates the CD8 T cells to release IFN-γ and TNF-α and to kill OVA-B16F10 melanoma cells. In animal mod... More

关键词

TCR avidity, TCR complex, immunoglobulin superfamily member 4, immunotherapy, transmembrane
XML 地图